Chordate Medical Holding AB Logo

Chordate Medical Holding AB

Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.

CMH | ST

Overview

Corporate Details

ISIN(s):
SE0021486131 (+1 more)
LEI:
549300R0GG2J3S0BFN79
Country:
Sweden
Address:
C/O Regus, 164 40 Kista
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Chordate Medical Holding AB is a medical technology company that has developed, patented, and CE-marked Ozilia®, a drug-free neuromodulation treatment technology. The product is designed for the treatment of chronic migraine and chronic rhinitis, offering a clinically proven alternative to conventional medication with minimal side effects. The company markets its treatment in selected markets within the EU and the Middle East. Its business strategy is focused on building value through clinical validation, an extensive patent portfolio, and commercial success stories to attract prospective buyers for a future exit.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Chordate Medical Holding AB and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Tommy Hedberg Other Other 2,917 11,668.00 SEK
2024-03-26 Anders Weilandt Other Buy 800,000 41,440.00 SEK
2024-03-26 Anders Weilandt Other Buy 200,000 10,540.00 SEK
2023-05-26 Anders Weilandt Other Buy 2,000,000 84,000.00 SEK
2023-05-26 Jan Hermansson Other Buy 750,000 31,500.00 SEK
2023-05-26 Nils Henrik Milton Rammer Other Other 350,000 14,700.00 SEK
2023-05-26 Caroline Brandberg Other Other 225,000 9,450.00 SEK
2023-05-26 Tommy Hedberg Other Buy 225,000 9,450.00 SEK
2023-01-09 Anders Weilandt Other Buy 3 2.10 SEK
2022-02-25 Anders Weilandt Other Buy 51,292 3,949,484.00 SEK

Peer Companies

Company Country Ticker View
Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden ACARIX
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland AME
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden ARCOMA
Develops software & hardware for precise surgical navigation and radiation therapy.
Germany N/A
Brainsway Ltd. Logo
Develops noninvasive Deep TMS therapy for depression, OCD, and smoking cessation.
Israel BWAY
Clinical Laserthermia Systems AB Logo
Develops image-guided laser ablation systems for urology and neurosurgery applications.
Sweden CLS
Cm International Spolka Akcyjna Logo
Designs & manufactures electronics for medical, aesthetic, and home appliance industries.
Poland CMI
Comet Holding AG Logo
Develops RF power and x-ray systems for semiconductor, electronics, auto, and aerospace industries.
Switzerland COTN
Develops wearable cyborgs to support physical functions in medicine, care, and labor.
Japan 7779
DELTEX MEDICAL GROUP PLC Logo
Develops Oesophageal Doppler Monitors for real-time blood flow data in surgery & critical care.
United Kingdom DEMG

Talk to a Data Expert

Have a question? We'll get back to you promptly.